Contraceptive Regimen Including Reduced Level of Estrogen
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- MILLICENT PHARMA LIMITED, Dundalk, Ireland has been assigned a patent (No. US 12138270 B2, initially filed Sept. 23, 2021) developed by Roger M. Boissonneault, Branford, Connecticut, and Ryan Loughlin, Banbridge, United Kingdom, for "Contraceptive regimen including reduced level of estrogen." . . .